Challenges to curing primary brain tumoursKenneth Aldape, Richard J. Gilbertson|Nature Reviews Clinical Oncology|2019Cited by 965
Novel mutations target distinct subgroups of medulloblastomaGiles Robinson, Richard J. Gilbertson, Jing Ma et al.|Nature|2012Cited by 853
ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Stephen C. Mack, Yanhua Zhao et al.|Cancer Discovery|2021Cited by 90
The NALCN channel regulates metastasis and nonmalignant cell disseminationEric P. Rahrmann, Richard J. Gilbertson|Nature Genetics|2022Cited by 76
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium studySri Gururangan, L. Kun, Jason Fangusaro et al.|Neuro-Oncology|2012Cited by 60